Increased expression of human thioredoxin/adult T cell leukemia-derived factor in Sjögren's syndrome

Arthritis and Rheumatism

Volumn 39, Issue 5, 1996, Pages 773-782

  Saito, Ichiro ^a   Shimuta, Misa ^a   Terauchi, Kumiko ^a   Tsubota, Kazuo ^b   Yodoi, Junji ^c   Miyasaka, Nobuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

THIOREDOXIN;

ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION; HUMAN; LYMPHOCYTIC INFILTRATION; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SJOEGREN SYNDROME; T CELL LEUKEMIA;

ADULT; AGED; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CYTOKINES; FEMALE; GENES, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MICE, SCID; MIDDLE AGED; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME; THIOREDOXIN; TRANSCRIPTION, GENETIC; TUMOR VIRUS INFECTIONS;

EID: 0029965926     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390509     Document Type: Article

References (44)

1. Bloch J, Buchanan W, Wohl M, Bunin J: Sjögren's syndrome: a clinical, pathological and serological study of 62 cases. Medicine (Baltimore) 44:187-231, 1965
2. Bell DA, Madden PJ: Serologic subsets in systemic sclerosis erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum 23:1268-1273, 1980
3. Mann DL, Moutsopoulos HM: HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members. Ann Rheum Dis 42:533-536, 1983
4. Manthorpe R, Teppo A-M, Bendixen G, Wegelius O: Antibodies to SS-B in chronic inflammatory connective tissue diseases: relationship with HLA-Dw2 and HLA-Dw3 antigens in primary Sjögren's syndrome. Arthritis Rheum 25:662-667, 1982
5. Morgan DG, Niederman JC, Miller G, Smith HW, Dowaliby JM: Site of Epstein-Barr virus replication in the oropharynx. Lancet ii: 1154-1157, 1979
6. Wolf H, Haus M, Wilmes E: Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795-798, 1984
7. Chang R, Lewis J, Abilguard C: Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med 289:1325-1329, 1973
8. Klein G: The Epstein-Barr virus. In, The Herpes Virus. Edited by A Kaplan. New York, Academic Press Inc, 1973
9. Birkenbach M, Tong X, Bradbury LE, Tedder TE, Kieff E: Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med 176:1405-1414, 1992
10. Chang R, Lewis J, Reynold R, Sullivan M, Newman J: Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann Intern Med 88:34-40, 1978
11. Li QX, Young LS, Niedobitek G, Dawson CW, Birkenbach M, Wang F, Rickinson AB: Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356:347-350, 1992
12. Fox RI, Pearson G, Vaughn JH: Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjögren's syndrome. J Immunol 137:3162-3168, 1986
13. Saito I, Servenius B, Compton T, Fox RI: Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J Exp Med 169:2191-2198, 1989
14. Mariette X, Gozlan J, Clerc D, Bisson M, Morinet F: Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reactions in salivary gland biopsy specimens from patients with Sjögren's syndrome. Am J Med 90:286-294, 1991
15. Yamaoka K, Miyasaka N, Yamamoto K: Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren's syndrome. Arthritis Rheum 31:1014-1021, 1988
16. Tateishi M, Saito I, Yamamoto K, Miyasaka N: Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell unes obtained from patients with Sjögren's syndrome. Arthritis Rheum 36:827-835, 1993
17. Tan EM: Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 33:167-240, 1983
18. Fox RI, Scott S, Houghton R, Whalley A, Geltofsky J, Vaughan JH, Smith R: Synthetic peptide derived from the Epstein-Barr virus encoded early diffuse antigen (EA-D) reactive with human antibodies. J Clin Lab Anal 1:140-145, 1987
19. Okada M, Maeda M, Tagaya Y, Taniguchi Y, Teshigawa K, Yoshiki T, Diamantstein T, Smith KA, Uchiyama T, Honjo T, Yodoi J: TCGF (IL2)-receptor inducing factor (s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I (+) T cell lines. J Immunol 135:3995-4003, 1985
20. Makino S, Matsutani H, Maekawa N, Konishi I, Fujii S, Yamamoto R, Yodoi J: Adult T-cell leukemia-derived factor/ thioredoxin expression on the HTLV-I transformed T-cell lines: heterogenous expression in ATL-2 cells. Immunology 76:578-583, 1992
21. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, Yodoi J, Tursz T: Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic Type-1 and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci U S A 87:8282-8286, 1990
22. Yodoi J, Uchiyama T: Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation. Immunol Today 13:405-411, 1992
23. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, Yodoi J: ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8:757-764, 1989
24. LeMaster DM: Nucleotide sequence and protein overproduction of bacteriophage T4 thioredoxin. J Virol 59:759-760, 1986
25. Sugie K, Kawakami T, Maeda Y, Kawabe T, Uchida A, Yodoi J: Fyn tyrosine kinase associated with Fc∈RIII/CD23: possible multiple roles in lymphocyte activation. Proc Natl Acad Sci USA 88:9132-9135, 1991
26. Wakasugi H, Rimsky L, Mahe Y, Kamel AM, Fradelizi D, Tursz T, Bertoglio J: Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor. Proc Natl Acad Sci U S A 84:804-808, 1987
27. Tagaya Y, Okada M, Sugie K, Kasahara T, Kondo N, Hamuro J, Matsushima K, Dinarello CA, Yodoi J: IL-2 Receptor(p55)/ Tac-inducing factor: purification and characterization of adult T cell leukemia-derived factor. J Immunol 140:2614-2620, 1988
28. Holmgren A: Thioredoxin. Annu Rev Biochem 54:237-271. 1985
29. Fox RI, Saito I: Criteria for diagnosis of Sjögren's syndrome. Rheum Dis Clin North Am 20:391-407, 1994
30. Tsubota K: The importance of the Schirmer test with nasal stimulation. Am J Opthalmal 111:106-108, 1991
31. Tagaya Y, Wakasugi H, Matsunani H, Nakamura H, Iwata S, Mitsui A, Fuji S, Wakasugi N, Tursz T, Yodoi J: Role of ATL-derived factor (ADF) in the normal and the abnormal cellular activation: involvement of dithiol related reduction. Mol Immunol 27:1279-1289, 1990
32. Lotz M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH: Release of lymphokines after infection with Epstein Barr virus in vitro. II. A monocyte-dependent inhibitor of interleukin 1 downregulates the production of interleukin 2 and interferon-g in rheumatoid arthritis. J Immunol 136:3643-3648, 1986
33. Okamoto Y, Shirotori K, Kudo K, Ishikawa K, Ito E, Togawa K, Saito I: Cytokine expression after the toropical administration of substance P to human nasal mucosa. J Immunol 151: 4391-1398, 1993
34. Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, Yamashita I, Iwata K, Tsuji Y, Nagataki S, Miyamoto T: Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet 344:1116-1119, 1994
35. Carry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H: Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250: 1127-1129, 1990
36. Menezes J, Jondal M, Leibold W, Dorval G: Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation. Infect Immun 13:303-310, 1976
37. Fox RI, Chilton T, Scott S, Benton L, Howell FV, Vaughan JH: Potentiol role of Epstein-Barr virus in Sjögren's syndrome. Rheum Dis Clin North Am 13:275-292, 1987
38. Pisa P, Cannon MJ, Pisa EK, Cooper NR, Fox RI: Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal. Blood 79: 173-179, 1992
39. Fujii S, Nanbu Y, Nonogaki H, Konishi I, Mori T, Masutani H, Yodoi J: Coexpression of Adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium. Cancer 68: 1583-1591, 1991
40. Abate C, Patel L, Rauscher FJ III, Curran T: Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249:1157-1161, 1990
41. Okamoto T, Ogiwara H, Hayashi T, Mitui A, Kawabe T, Yodai J: Human thioredoxin/adult T cell leukemia-derived facter activates the enhancer binding protein of human immunodeficiency virus type I by thioledox control mechanism. Int Immunol 4:811-819, 1992
42. Fox RI, Kang H-L, Ando D, Abrames J. Pisa E: Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 152:5532-5539, 1994
43. Lots M, Tsoukas CD, Fong S, Dinarello CA, Carson DA, Vaughan JH: Release of lymphokines after infection with Epstein-Barr virus in vitro. J Immunol 136:3643-3648, 1986
44. Haddad J, Deny P, Munz-Gotheil C, Ambrosini J. Trinchet J, Pateron D, Mal F, Callard P, Beaugrand M: Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323, 1992